J Cell Mol Med. 2024 Aug;28(15):e18567. doi: 10.1111/jcmm.18567.
Li, Z., Shen, J., Chan, M. T. V., and Wu, W. K. K. (2017). Microrna-379 Suppresses Osteosarcoma Progression by Targeting PDK1. Journal of Cellular and Molecular Medicine, 21(2), 315-323. https://doi.org/10.1111/jcmm.12966 The above article, published online on 25 October 2016 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figures 2D, 3, 4G, 6A and F) within the article and between this and other articles that were previously published or published shortly after in a different scientific context. The authors were unable to provide a satisfactory explanation and the provided raw data could not explain the identified issues, which has led the editors to lose confidence in the data presented. Therefore, the editors consider the conclusions substantially compromised and are retracting the paper. The co-author, J. Shen stated that they were not involved in this research and had no knowledge about its publication, and their correspondence email address was added without their consent. The authors, including Z. Li who submitted the manuscript, were informed of the decision to retract but did not respond to the retraction or the retraction wording.
李，Z.，沈，J.，陈，M. T. V.，和吴，W. K. K.（2017年）。微小RNA - 379通过靶向PDK1抑制骨肉瘤进展。《细胞与分子医学杂志》，21(2)，315 - 323。https://doi.org/10.1111/jcmm.12966 上述文章于2016年10月25日在线发表于威利在线图书馆（wileyonlinelibrary.com），已由期刊主编斯特凡·康斯坦丁内斯库、细胞与分子医学基金会以及约翰·威利父子有限公司协商后撤回。此次撤回是在对第三方提出的担忧进行调查之后达成的，调查发现文章内部以及该文章与之前发表或在不同科学背景下不久后发表的其他文章之间存在图像板块（图2D、3、4G、6A和F）的不当重复。作者无法提供令人满意的解释，所提供的原始数据也无法解释所发现的问题，这导致编辑们对所呈现的数据失去信心。因此，编辑们认为结论受到严重影响，现撤回该论文。共同作者J.沈表示他们未参与此项研究，对其发表情况不知情，且他们的通信电子邮件地址未经同意就被添加了。包括提交稿件的李，Z.在内的作者已被告知撤回决定，但未对撤回或撤回措辞做出回应。
